Ingenix, a United Health information technology and services company, is acquiring Executive Health Resources, a provider of medical necessity compliance and physician medical management solutions for hospitals.
Ingenix, a United Health information technology and services company, is acquiring Executive Health Resources, a provider of medical necessity compliance and physician medical management solutions for hospitals. The transaction is expected to close this year.
Executive Health Resources, based in Newtown Square, Pa., serves more than 1,100 hospital and health system clients nationwide. Its clients include for-profit and non-profit systems, academic medical centers, community hospitals and specialty centers. Executive Health Resources’ Physician Advisor teams provide hospitals and health systems with technology-supported services to managing compliance with Centers for Medicare & Medicaid Services (CMS), and state-directed medical necessity rules and regulations. Congress expanded federal auditing oversight in 2006 to all 50 U.S. states in an effort to reduce federal payment discrepancies with hospitals.
Ingenix, based in Eden Prairie, Minn., offers consulting, information systems and services designed to help hospitals improve operational efficiency.
“The regulatory landscape is complex and ever-changing, and compliance has become a crucial aspect of a hospital’s operational integrity,” said Dr. Robert Corrato, in a statement. Corrato is president and chief executive officer of Executive Health Resources. “As we continue to support our clients in this rapidly growing market with solutions that simplify the compliance process, Ingenix’s impressive data assets and sophisticated technologies will help us to more quickly deliver critical, technology-enabled intelligence for our clients.”
In this first part of a two-part podcast episode, Managed Healthcare Executive's Managing Editor Peter Wehrwein kicks off our new podcast series "DC Roundtable," with guests Margaret "Meg" Murray, CEO of the Association of Community Affiliated Plans, and member of MHE's Editorial Advisory Board, and CeCi Connolly, president and CEO of the Alliance of Community Health Plans, for a discussion on healthcare policy issues.
Listen
New approvals this week include a $4.25 million gene therapy, a drug that treats hypertension in a new way, a nonsteroidal drug for Duchenne, and an oral drug for aggressive leukemia. The agency has set an action date for resubmitted Lymphir in rare skin cancer, and Celltrion has launched Zymfentra, a subcutaneous form of infliximab.
Read More